Celldex Therapeutics shares owned by Octagon Capital Advisors
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Octagon Capital Advisors
from 13F filings
Historical chart of Octagon Capital Advisors investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Octagon Capital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Celldex Therapeutics by Octagon Capital Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $28M | 708k | 39.66 |
2023-09-30 | $21M | 760k | 27.52 |
2023-06-30 | $26M | 760k | 33.93 |
2023-03-31 | $27M | 760k | 35.98 |
2022-12-31 | $34M | 761k | 44.57 |
2022-09-30 | $21M | 761k | 28.11 |
2022-06-30 | $21M | 761k | 26.96 |
2022-03-31 | $26M | 761k | 34.06 |
2021-12-31 | $29M | 761k | 38.64 |
2021-09-30 | $41M | 761k | 53.99 |
2021-06-30 | $19M | 561k | 33.44 |
2021-03-31 | $12M | 561k | 20.60 |
2020-12-31 | $18M | 1.0M | 17.52 |